Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives
Xiu-Zheng Gao,Xu-Tao Lv,Rui-Rui Zhang,Yang Luo,Mu-Xuan Wang,Jia-Shu Chen,Yu-Kai Zhang,Bin Sun,Jin-Yue Sun,Yu-Fa Liu,Chao Liu,Xiu-zheng Gao,Xu-tao Lv,Rui-rui Zhang,Mu-xuan Wang,Jia-shu Chen,Yu-kai Zhang,Jin-yue Sun,Yu-fa Liu
DOI: https://doi.org/10.1016/j.bioorg.2021.104694
IF: 5.307
2021-04-01
Bioorganic Chemistry
Abstract:<p>Cancer treatment is one of the major public health issues in the world. Tetrandrine (Tet) and fangchinoline (<em>d</em>-Tet) are two <em>bis</em>-benzyl isoquinoline alkaloids extracted from <em>Stephania tetrandra</em> S. Moore, and their antitumor activities have been confirmed. However, the effective dose of Tet and <em>d</em>-Tet were much higher than that of the positive control and failed to meet clinical standards. Therefore, in this study, as a continuation of our previous work to study and develop high-efficiency and low-toxic anti-tumor lead compounds, twenty new Tet and <em>d</em>-Tet derivatives were designed, synthesized and evaluated as antitumor agents against six cancer cell lines (H460, H520, HeLa, HepG-2, MCF-7, SW480 cell lines) and BEAS-2B normal cells by CCK-8 analysis. Ten derivatives showed better cytotoxic effects than the parent fangchinoline, of which <strong>4g</strong> showed the strongest cell growth inhibitory activity with an IC<sub>50</sub> value of 0.59 μM against A549 cells. Subsequently, the antitumor mechanism of <strong>4g</strong> was studied by flow cytometry, Hoechst 33258, JC-1 staining, cell scratch, transwell migration, and Western blotting assays. These results showed that compound <strong>4g</strong> could inhibit A549 cell proliferation by arresting the G2/M cell cycle and inhibiting cell migration and invasion by reducing MMP-2 and MMP-9 expression. Meanwhile, <strong>4g</strong> could induce apoptosis of A549 cells through the intrinsic pathway regulated by mitochondria. In addition, compound <strong>4g</strong> inhibited the phosphorylation of PI3K, Akt and mTOR, suggesting a correlation between blocking the PI3K/Akt/mTOR pathway and the above antitumor activities. These results suggest that compound <strong>4g</strong> may be a future drug for the development of new potential drug candidates against lung cancer.</p>
biochemistry & molecular biology,chemistry, organic